Match!
Esther W. de Bekker-Grob
Erasmus University Rotterdam
Health carePhysical therapyDiscrete choiceVaccinationMedicine
89Publications
24H-index
1,941Citations
What is this?
Publications 101
Newest
#1C Whichello (EUR: Erasmus University Rotterdam)H-Index: 2
#2Bennett Levitan (Janssen Pharmaceutica)H-Index: 12
Last. Esther W. de Bekker-Grob (EUR: Erasmus University Rotterdam)H-Index: 24
view all 7 authors...
Incorporating patient preference (PP) information into decision-making has become increasingly important to many stakeholders. However, there is little guidance on which patient preference assessment methods, including preference exploration (qualitative) and elicitation (quantitative) methods, are most suitable for decision-making at different stages in the medical product lifecycle (MPLC). This study aimed to use an empirical approach to assess which attributes of PP assessment methods are mos...
Source
#1Ilgin Arslan (EUR: Erasmus University Rotterdam)
#2Sp Huls (EUR: Erasmus University Rotterdam)
Last. Dieuwke SchiphofH-Index: 12
view all 6 authors...
BACKGROUND Despite the wide range of treatment options for knee and hip osteoarthritis (KHOA), suboptimal care, low uptake and low adherence to treatment is widely seen. We need to gain insight into preferences for KHOA treatment. AIM To determine patients', healthcare providers' and healthcare insurance employees' preferences for existing health care for KHOA. METHOD A survey containing a discrete choice experiment (DCE) was conducted. Patients with KHOA, healthcare providers (orthopaedists and...
Source
#1Marcel F. JonkerH-Index: 8
#2Bas DonkersH-Index: 24
Last. Sl WongH-Index: 2
view all 9 authors...
Objective. Quantitatively summarize patient preferences for European licensed relapsing-remitting multiple sclerosis (RRMS) disease-modifying treatment (DMT) options. Methods. To identify and summa...
Source
#1Esther W. de Bekker-Grob (EUR: Erasmus University Rotterdam)H-Index: 24
#2Bas Donkers (EUR: Erasmus University Rotterdam)H-Index: 24
Last. Joffre Swait (EUR: Erasmus University Rotterdam)H-Index: 1
view all 5 authors...
Abstract Lack of evidence about the external validity of Discrete Choice Experiments (DCEs)-sourced preferences inhibits greater use of DCEs in healthcare decision-making. This study examines the external validity of such preferences, unravels its determinants, and provides evidence of whether healthcare choice is predictable. We focused on influenza vaccination and used a six-step approach: i) literature study, ii) expert interviews, iii) focus groups, iv) survey including a DCE, v) field data,...
Source
#1Eline van Overbeeke (Katholieke Universiteit Leuven)H-Index: 3
#2Rosanne Janssens (Katholieke Universiteit Leuven)H-Index: 1
Last. Isabelle Huys (Katholieke Universiteit Leuven)H-Index: 21
view all 19 authors...
Objectives: To investigate stakeholder perspectives on how patient preference studies (PPS) should be designed and conducted to allow for inclusion of patient preferences in decision-making along the medical product life cycle (MPLC), and how patient preferences can be used in such decision-making. Methods: Two literature reviews and semi-structured interviews (n=143) with healthcare stakeholders in Europe and the US were conducted; results of these informed the design of focus group guides. Eig...
1 CitationsSource
#1Jennifer A. Whitty (UEA: University of East Anglia)H-Index: 23
#2Esther W. de Bekker-Grob (EUR: Erasmus University Rotterdam)H-Index: 24
Last. Hans L. Hillege (UMCG: University Medical Center Groningen)H-Index: 88
view all 7 authors...
There is an emerging consensus that evidence on patients’ perspectives provides crucial guidance for decision making throughout the medical product lifecycle (MPLC). Consid-ering the patient voice has become increasingly important for developers of new medical products and for authorities that assess, regulate and decide which products are effective, safe, well tolerated and cost effective [1, 2]. However, as key stakeholders, we lack a shared understanding about how to consider patient preferen...
1 CitationsSource
Source
#1Vikas SoekhaiH-Index: 2
#2Bas DonkersH-Index: 24
Last. Esther W. de Bekker-GrobH-Index: 24
view all 3 authors...
Source
#1Samare P.I. Huls (EUR: Erasmus University Rotterdam)
#2C Whichello (EUR: Erasmus University Rotterdam)H-Index: 2
Last. Esther W. de Bekker-Grob (EUR: Erasmus University Rotterdam)H-Index: 24
view all 5 authors...
Abstract Background Integrating patient preferences in Health Technology Assessment (HTA) is argued to improve uptake, adherence, and patient satisfaction. However, how to elicit and incorporate these preferences in HTA in a systematic and scientifically valid manner is subject to debate. Objective This article provides a systematic review of the challenges to integrating patient preferences in HTA that have been raised in the literature about patient preferences in HTA. Methods A systematic rev...
Source
#1C WhichelloH-Index: 2
#2Bennett LevitanH-Index: 12
Last. Esther W. de Bekker-GrobH-Index: 24
view all 5 authors...
Source
12345678910